National Comprehensive Cancer Network

Genomic cancer predisposition tests should be done with professional counseling, and the FDA should implement safeguards for direct-to-consumer products, according to a medical oncologist with expertise in cancer genetics.

Diversity and equity in health care doesn’t just benefit underrepresented populations.

Two common platinum-based chemotherapies that had been in short supply for most of the past year are much more widely available this summer, according to results of a new National Comprehensive Cancer Network survey.

Effective counseling for people with cancer about sexual and reproductive health must account for the individual’s personal story, gender identity and long-term goals of care, according to a speaker.

A National Comprehensive Cancer Network Annual Conference plenary session examined the impact of drug shortages on oncology care, as well as potential solutions.

Matt Kalaycio, MD, FACP, has been elected chair of National Comprehensive Cancer Network’s board of directors.

Determining risk classifications of children with neuroblastoma is “paramount” to optimizing their care, the chair of the first National Comprehensive Cancer Network guidelines panel on the disease, told Healio.

Social determinants of health have become a key component of oncology research, providing insights into how factors such as race, ethnicity, socioeconomic status, and sexual or gender identity influence cancer incidence or outcomes.

Most U.S. cancer centers reported experiencing a shortage of at least one type of oncology drug, according to the results of a National Comprehensive Cancer Network survey on chemotherapy shortages.

National Comprehensive Cancer Network’s Oncology Research Program awarded three grants to support research into small cell lung cancer.